NovaBay Pharmaceuticals Inc (NBY)
0.1036
+0.02
(+23.33%)
USD |
NYAM |
May 15, 16:00
0.102
0.00 (0.00%)
After-Hours: 20:00
NovaBay Pharmaceuticals Cash from Operations (Quarterly): -1.572M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -1.572M |
December 31, 2023 | -0.314M |
September 30, 2023 | -0.363M |
June 30, 2023 | -2.267M |
March 31, 2023 | -1.187M |
December 31, 2022 | -1.209M |
September 30, 2022 | -1.689M |
June 30, 2022 | -1.699M |
March 31, 2022 | -2.057M |
December 31, 2021 | -4.318M |
September 30, 2021 | -1.468M |
June 30, 2021 | -1.987M |
March 31, 2021 | -1.419M |
December 31, 2020 | -1.445M |
September 30, 2020 | -1.37M |
June 30, 2020 | -1.041M |
March 31, 2020 | -0.865M |
December 31, 2019 | -1.429M |
September 30, 2019 | -1.50M |
June 30, 2019 | -1.779M |
March 31, 2019 | -3.221M |
December 31, 2018 | -1.993M |
September 30, 2018 | -1.618M |
June 30, 2018 | -1.493M |
March 31, 2018 | -0.464M |
Date | Value |
---|---|
December 31, 2017 | -2.926M |
September 30, 2017 | 0.281M |
June 30, 2017 | -1.619M |
March 31, 2017 | -2.006M |
December 31, 2016 | -0.22M |
September 30, 2016 | -3.849M |
June 30, 2016 | -2.659M |
March 31, 2016 | -4.933M |
December 31, 2015 | -4.489M |
September 30, 2015 | -4.138M |
June 30, 2015 | -5.425M |
March 31, 2015 | -4.507M |
December 31, 2014 | -4.14M |
September 30, 2014 | -2.746M |
June 30, 2014 | -3.753M |
March 31, 2014 | -4.416M |
December 31, 2013 | -4.675M |
September 30, 2013 | -2.406M |
June 30, 2013 | -2.196M |
March 31, 2013 | -3.692M |
December 31, 2012 | -3.096M |
September 30, 2012 | 0.258M |
June 30, 2012 | -0.954M |
March 31, 2012 | -2.736M |
December 31, 2011 | -0.589M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-4.318M
Minimum
Dec 2021
-0.314M
Maximum
Dec 2023
-1.549M
Average
-1.456M
Median
Cash from Operations (Quarterly) Benchmarks
Eyenovia Inc | -6.322M |
Palatin Technologies Inc | -10.48M |
iBio Inc | -4.706M |
Theriva Biologics Inc | -4.881M |
Oragenics Inc | -1.102M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 1.068M |
Cash from Financing (Quarterly) | -0.597M |
Free Cash Flow | -4.524M |
Free Cash Flow Per Share (Quarterly) | -0.0638 |
Free Cash Flow to Equity (Quarterly) | -1.444M |
Free Cash Flow Yield | -399.1% |